Drugs / fibronectin assisted retroviral vector expressing human O6-methylguanine DNA methyltransferase
fibronectin assisted retroviral vector expressing human O6-methylguanine DNA methyltransferase
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00005796 | Feb 2000 → Jun 2003 | bone marrow disorder, central nervous system neoplasm, chemotherapy-induced toxicity | Indiana University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fibronectin assisted retroviral vector expressing human O6-methylguanine DNA methyltransferase | “transduced with a fibronectin assisted retroviral vector expressing human O6-methylguanine DNA methyltransferase” NCT00005796 ↗ |